These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17617002)

  • 1. Intraductal carcinoma of the prostate gland with transmucosal spread to the seminal vesicle: a lesion distinct from high-grade prostatic intraepithelial neoplasia.
    Cohen RJ; Shannon BA; Weinstein SL
    Arch Pathol Lab Med; 2007 Jul; 131(7):1122-5. PubMed ID: 17617002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma.
    Cohen RJ; Wheeler TM; Bonkhoff H; Rubin MA
    Arch Pathol Lab Med; 2007 Jul; 131(7):1103-9. PubMed ID: 17616999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.
    Haffner MC; Weier C; Xu MM; Vaghasia A; Gürel B; Gümüşkaya B; Esopi DM; Fedor H; Tan HL; Kulac I; Hicks J; Isaacs WB; Lotan TL; Nelson WG; Yegnasubramanian S; De Marzo AM
    J Pathol; 2016 Jan; 238(1):31-41. PubMed ID: 26331372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.
    Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
    Int J Clin Exp Pathol; 2014; 7(5):2518-26. PubMed ID: 24966964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate.
    Bettendorf O; Schmidt H; Staebler A; Grobholz R; Heinecke A; Boecker W; Hertle L; Semjonow A
    Genes Chromosomes Cancer; 2008 Jul; 47(7):565-72. PubMed ID: 18383208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression.
    Dawkins HJ; Sellner LN; Turbett GR; Thompson CA; Redmond SL; McNeal JE; Cohen RJ
    Prostate; 2000 Sep; 44(4):265-70. PubMed ID: 10951489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-Depth Comparison of Genetic Variants Demonstrates a Close Relationship Between Invasive and Intraductal Components of Prostate Cancer.
    Vormittag-Nocito E; Acosta AM; Agarwal S; Narayan KD; Kumar R; Al Rasheed MRH; Kajdacsy-Balla A; Behm FG; Mohapatra G
    Mod Pathol; 2023 Jun; 36(6):100130. PubMed ID: 36933394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.
    Hickman RA; Yu H; Li J; Kong M; Shah RB; Zhou M; Melamed J; Deng FM
    Am J Surg Pathol; 2017 Apr; 41(4):550-556. PubMed ID: 28009609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion.
    Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
    Hum Pathol; 2014 Aug; 45(8):1572-81. PubMed ID: 24842280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.
    Iczkowski KA; Egevad L; Ma J; Harding-Jackson N; Algaba F; Billis A; Camparo P; Cheng L; Clouston D; Comperat EM; Datta MW; Evans AG; Griffiths DF; Guo CC; Hailemariam S; Huang W; Humphrey PA; Jiang Z; Kahane H; Kristiansen G; La Rosa FG; Lopez-Beltran A; MacLennan GT; Magi-Galluzzi C; Merrimen J; Montironi R; Osunkoya AO; Picken MM; Rao N; Shah RB; Shanks JH; Shen SS; Tawfik OW; True LD; Van der Kwast T; Varma M; Wheeler TM; Zynger DL; Sahr N; Bostwick DG
    Ann Diagn Pathol; 2014 Dec; 18(6):333-42. PubMed ID: 25263387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premalignancy in Prostate Cancer: Rethinking What we Know.
    De Marzo AM; Haffner MC; Lotan TL; Yegnasubramanian S; Nelson WG
    Cancer Prev Res (Phila); 2016 Aug; 9(8):648-56. PubMed ID: 26813971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-grade prostatic intraepithelial neoplasia, PIN-like carcinoma, ductal carcinoma, and intraductal carcinoma of the prostate.
    Zhou M
    Mod Pathol; 2018 Jan; 31(S1):S71-79. PubMed ID: 29297491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraductal Carcinoma of the Prostate without High-Grade Invasive Adenocarcinoma: Report of Two Cases and Review of the Literature.
    Ortiz-Rey JA; Bellas-Pereira A; San Miguel-Fraile P; Morellón-Baquera R; Domínguez-Arístegui P; González-Carreró Fojón J
    Arch Esp Urol; 2022 Nov; 75(9):738-745. PubMed ID: 36472055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraductal Carcinoma of the Prostate Gland: Recent Advances.
    Divatia MK; Ro JY
    Yonsei Med J; 2016 Sep; 57(5):1054-62. PubMed ID: 27401634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desquamating apoptotic variant of high-grade prostatic intraepithelial neoplasia: a possible precursor of intraductal prostatic carcinoma.
    Cohen RJ; O'Brien BA; Wheeler TM
    Hum Pathol; 2011 Jun; 42(6):892-5. PubMed ID: 21288556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.
    Han B; Suleman K; Wang L; Siddiqui J; Sercia L; Magi-Galluzzi C; Palanisamy N; Chinnaiyan AM; Zhou M; Shah RB
    Am J Surg Pathol; 2010 Apr; 34(4):478-85. PubMed ID: 20220513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a comparative clinicopathological and molecular study with a proposal to expand the morphological spectrum of intraductal carcinoma.
    Shah RB; Yoon J; Liu G; Tian W
    Histopathology; 2017 Nov; 71(5):693-702. PubMed ID: 28570007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis.
    Quick CM; Gokden N; Sangoi AR; Brooks JD; McKenney JK
    Hum Pathol; 2010 Aug; 41(8):1145-9. PubMed ID: 20413145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer.
    Wilcox G; Soh S; Chakraborty S; Scardino PT; Wheeler TM
    Hum Pathol; 1998 Oct; 29(10):1119-23. PubMed ID: 9781651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraductal Adenocarcinoma of the Prostate With Cribriform or Papillary Ductal Morphology: Rare Biopsy Cases Lacking Associated Invasive High-grade Carcinoma.
    Russell DH; Epstein JI
    Am J Surg Pathol; 2022 Feb; 46(2):233-240. PubMed ID: 34619708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.